Generated single point-mutations can considerably dismantle the lymphocyte overstimulation induced by Yersinia pseudotuberculosis superantigen

被引:3
作者
Seprényi, G [1 ]
Ito, Y [1 ]
Kohsaka, T [1 ]
机构
[1] Natl Childrens Med Res Ctr, Dept Immunol, Setagaya Ku, Tokyo 1648509, Japan
关键词
D O I
10.1006/cimm.1998.1451
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The superantigenic Yersinia pseudotuberculosis-derived mitogen (YPM) may contribute to severe complications in Y. pseudotuberculosis infections. Since the pathogenic mechanism of a superantigen (SAg) is based on its capability for T-cell overstimulation, by introducing point mutations into YPM an attempt was made to abrogate this effect. Six mutants studied exhibited a variety of T-cell proliferating responses. Two had activity reduced by 80-90%, three had activity reduced by similar to 50%, and one mutant showed almost no attenuation. The SAg-associated in vitro pathogenic functions, cytotoxic activation and the production of proinflammatory cytokines, were also diminished, in parallel. Since these mutants were confirmed to be defective in TCR VP binding, it was possible to compare them with native YPM. Our results suggested that the intensity of TCR VP binding is a crucial factor determining the severity of pathogenesis and that single amino acid alterations might be useful for producing immunotherapeautical agents from native YPM. (C) 1999 Academic Press.
引用
收藏
页码:96 / 106
页数:11
相关论文
共 38 条
[1]   Clinical role for a superantigen in Yersinia pseudotuberculosis infection [J].
Abe, J ;
Onimaru, M ;
Matsumoto, S ;
Noma, S ;
Baba, K ;
Ito, Y ;
Kohsaka, T ;
Takeda, T .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (08) :1823-1830
[2]  
ABE J, 1993, J IMMUNOL, V151, P4183
[3]   SUPERANTIGEN ENGINEERING [J].
ABRAHMSEN, L .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1995, 5 (04) :464-470
[4]   B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28 [J].
AZUMA, M ;
ITO, D ;
YAGITA, H ;
OKUMURA, K ;
PHILLIPS, JH ;
LANIER, LL ;
SOMOZA, C .
NATURE, 1993, 366 (6450) :76-79
[5]   Superantigen vaccines: A comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A [J].
Bavari, S ;
Dyas, B ;
Ulrich, RG .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (02) :338-345
[6]  
BONACH GA, 1990, CRIT REV MICROBIOL, V17, P251
[7]   A MUTATION AT HISTIDINE RESIDUE-135 OF TOXIC-SHOCK-SYNDROME TOXIN YIELDS AN IMMUNOGENIC PROTEIN WITH MINIMAL TOXICITY [J].
BONVENTRE, PF ;
HEEG, H ;
EDWARDS, CK ;
CULLEN, CM .
INFECTION AND IMMUNITY, 1995, 63 (02) :509-515
[8]   INTERFERON - A CYTOTOXIC LYMPHOCYTE-T DIFFERENTIATION SIGNAL [J].
CHEN, LK ;
TOURVIEILLE, B ;
BURNS, GF ;
BACH, FH ;
MATHIEUMAHUL, D ;
SASPORTES, M ;
BENSUSSAN, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (07) :767-770
[9]  
DORAZIO JA, 1995, J IMMUNOL, V154, P1014
[10]   Proinflammatory cytokines: Indicators of infection in high-risk patients [J].
Fassbender, K ;
Dempfle, CE ;
Mielke, O ;
Rossol, S ;
Schneider, S ;
Dollman, M ;
Hennerici, M .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (05) :535-539